Jubilant Pharmova Ltd (JUBLPHARMA) is listed on the NSE in the Pharmaceuticals sector, Pharmaceuticals & Biotechnology industry. Market capitalisation: 15290.99 Cr. Figures below are as reported and are shown with their source and date.
Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. The company is headquartered in Noida, Uttar Pradesh and currently employs 1,034 full-time employees. The firm's segments include Pharmaceuticals, Contract Research and Development Services and Proprietary Novel Drugs. The Pharmaceuticals segment, through wholly owned subsidiary Jubilant Pharma Limited, is engaged in manufacture and supply of active pharmaceutical ingredients (APIs), solid dosage formulations, radiopharmaceuticals, allergy therapy products and contract manufacturing of sterile injectables and non-sterile products through six manufacturing facilities in India, United States and Canada and a network of approximately 48 radio pharmacies in the United States. The Contract Research and Development Services segment provides drug discovery and development services as well as clinical data software and service solutions. The Proprietary Novel Drugs segment is a patient-focused biopharmaceutical business working to address unmet medical needs in oncology and autoimmune diseases.
Source: finedge · as of 2026-09-29
Last close (₹): 929.4
Source: quantro_screener_metrics_job · as of 2026-10-21
Source: quantro_screener_metrics_job · as of 2026-10-22
| Year ended | Revenue (₹ Cr) | PAT (₹ Cr) | EPS (₹) |
|---|---|---|---|
| Mar 2026 | 8,279.6 | 398.5 | 25.02 |
| Mar 2025 | 7,234.5 | 839.4 | 52.7 |
| Mar 2024 | 670.29 | 7.71 | 0.48 |
| Mar 2023 | 6,281.73 | -60.98 | -3.83 |
| Mar 2022 | 6,059.17 | 413.94 | 25.99 |
Source: finedge · as of 2026-07-21
Source: finedge · as of 2026-03-31
Source: quantro_company_profiles · as of 2026-10-22
Figures computed 2026-10-22.